{"name":"Haider Mahdi","slug":"haider-mahdi","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPV0VkLXRsR2ZWRzdZWlltcTlOMTZaeTc1bFRnSDA2ajJvQzdlUDBfRndNMXZ1NUF0M2VPVE1ZYmJZczE2ampTa0NaN0RBSUlJaVVJdUN3aDd0TXZuWHNBODRwNk8zSm50emwwc1JzY3NUSzRyWTIydVV2VmNxbFRhQlZqaUFxN3kzRWc1S1Mwc292WlNoVGlrWmQ3cVFPY2ZIZlNxTzJ5Vk52MU1S?oc=5","date":"2024-11-11","type":"pipeline","source":"Contract Pharma","summary":"Citius’ LYMPHIR Shows Potential to Boost Pembrolizumab Efficacy - Contract Pharma","headline":"Citius’ LYMPHIR Shows Potential to Boost Pembrolizumab Efficacy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}